ConSynance Therapeutics

ConSynance Therapeutics is a clinical-stage biopharmaceutical company focused on rare central nervous system disorders. Our goal is to translate groundbreaking science into transformative therapies for patients, with a particular focus on diseases related to hypothalamic dysfunction, including Prader-Willi Syndrome, obesity caused by hypothalamic injury, and narcolepsy.